Vincent Fallet
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysis.
Journal: Translational lung cancer research
Published: March 27, 2026
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 23, 2025
Efficacy and safety of second-line treatments in patients with advanced EGFR-mutated non-small cell lung cancer progressing on osimertinib without identified targetable resistance mechanism at progression.
Journal: Respiratory medicine and research
Published: October 12, 2025
European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: September 24, 2025
Pulmonary toxicity of immune-checkpoint inhibitors.
Journal: Presse medicale (Paris, France : 1983)
Published: July 27, 2025
European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.
Journal: The European respiratory journal
Published: January 23, 2025
Mpox Hepatic and Pulmonary Lesions in HIV/Hepatitis B Virus Co-Infected Patient, France.
Journal: Emerging infectious diseases
Published: October 24, 2024
Management of non-small cell lung cancer after 2 years of immunotherapy.
Journal: Respiratory medicine and research
Published: October 03, 2024
Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 27, 2024
Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 06, 2024
Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC.
Journal: JTO clinical and research reports
Published: July 05, 2024
Increased delays of care during the COVID-19 pandemic: experience of a lung cancer rapid diagnostic center.
Journal: Respiratory medicine and research
Published: April 11, 2024
Last Updated: 09/26/2026